Mucosal Atomization Devices Market Size, Share, And Growth Rate Analysis 2023
The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032
The Business Research Company’s mucosal atomization devices market report forecasts the mucosal atomization devices market size to grow to $1.07 Billion by 2027, with a CAGR (compound annual growth rate) of more than 8%.
Learn More On The Mucosal Atomization Devices Market Report 2023 – https://www.thebusinessresearchcompany.com/report/mucosal-atomization-devices-global-market-report
Mucosal Atomization Devices Market Size Forecast
The global mucosal atomization devices market is expected to grow from $0.72 billion in 2022 to $0.78 billion in 2023 at a compound annual growth rate (CAGR) of 8.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The mucosal atomization devices market size is expected to grow to $1.07 billion in 2027 at a CAGR of 8.4%.
North America held the largest mucosal atomization devices market share, and Asia-Pacific was the fastest-growing region in 2022.
Key Mucosal Atomization Devices Market Driver – Increase In Prevalence Of Allergic Rhinitis And Sinus Across The World
According to the data published by ‘Sinus and Allergy Wellness Centre’, a US-based organization, in the United States, in 2020, sinusitis has impacted 300 million or 11.6% of American adults. Therefore, the increasing prevalence of allergic rhinitis and sinus across the world drives the growth of the mucosal atomization devices market.
Request for A Sample Of The Global Mucosal Atomization Devices Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7440&type=smp
Key Mucosal Atomization Devices Market Trend – Strategic Partnerships
Major companies operating in mucosal atomization devices are undergoing partnerships to strengthen their position in the market. For instance, in October 2021, Pulmodyne Inc., a US-based company that provides drug atomization delivery, partnered with Alcove Manufacturing and Distribution Inc., a UK-based company with this partnership, The EZ-Spray Atomization System will start to be distributed by Pulmodyne through its current channels. The cooperation aims to advance industry innovation in addition to distribution, and this connection will enable the two seasoned businesses to quickly optimize product designs.
Mucosal Atomization Devices Market Segment
1) By Type: Nasal Atomization Devices, Fiber-Optic Atomization Devices, Laryngo-Tracheal Atomization Devices, Bottle Atomizer Devices
2) By Technology: Gas Propelled Atomization Devices, Electrical Atomization Devices
3) By End User: Hospitals, Ambulatory Surgical Centers, Specialized Clinics
Mucosal Atomization Devices Market Major Players and Strategies
Major players in the mucosal atomization devices market are Teleflex Incorporated, DeVilbiss Healthcare LLC, Becton Dickinson and Company, Kurve Therapeutics, Cook, Medica Holdings LLC, Life-Assist Inc., MedTree (BTME Group Ltd), Integra LifeSciences, BVM Meditech Private Limited, Drive Medical, DS Medical, Wolfetory Medical Inc., MILA International, and Magal Healthcare Pvt Ltd.
In March 2022, Kurve Technology Inc., a US-based company that engaged in the development of liquid drug delivery devices for topical, systemic, and nose-to-brain medical therapies, merged with Savile Therapeutics Inc. This merger allows Kurve Technology to gain access to the assets of Savile Therapeutics Inc and drive further growth and expansion. Savile Therapeutics Inc is a US-based medical device company.
The Mucosal Atomization Devices Global Market Report 2023 covers regional data on mucosal atomization devices market size, mucosal atomization devices market trends and drivers, opportunities, strategies, and mucosal atomization devices market competitor analysis. The countries covered in the mucosal atomization devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
Mucosal atomization devices offer medication through the nostrils. It is known for providing dependable topical solution atomization across the nasal and oropharyngeal mucous membranes. The mucosal atomization devices are used to deliver atomized medication to the mucosal surfaces of the nasal, oral, and larynx, trachea, and lungs.
View More Reports Related To The Mucosal Atomization Devices Market –
Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2023
Prosthetic Heart Valve Devices And Equipment Global Market Report 2023
Voice Prosthesis Devices And Equipment Global Market Report 2023
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: